Skip to content

Geron GERN Change in Inventories

Change in Inventories at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$14M-108%
Incyte logo
IncyteINCY
$12.23M-57.2%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$2.06M-50.8%
Exelixis logo
ExelixisEXEL
$3.39M+4,673%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$77.8M+119%
Gilead Sciences logo
Gilead SciencesGILD
$52M-76.7%

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$878.88M-8.6%
Enterprise value$964.15M-6.2%
P/S4.7×-172×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's change in inventories?
Geron (GERN) reported change in inventories of $16.65M in Q1 2026.
How has Geron's change in inventories changed year-over-year?
Geron's change in inventories decreased by 4.9% year-over-year, from $17.51M to $16.65M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.